CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.

about

CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles.

Item

http://www.wikidata.org/entity/Q47347862

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CALR mutational status identif ...... distinct expression profiles.

@en

CALR mutational status identif ...... distinct expression profiles.

@nl

type

Item

label

CALR mutational status identif ...... distinct expression profiles.

@en

CALR mutational status identif ...... distinct expression profiles.

@nl

prefLabel

CALR mutational status identif ...... distinct expression profiles.

@en

CALR mutational status identif ...... distinct expression profiles.

@nl

P1476

CALR mutational status identif ...... distinct expression profiles.

@en

P2093

AGIMM (AIRC Gruppo Italiano Malattie Mieloproliferative) investigators

http://www.w3.org/2001/XMLSchema#string

Alessandro M Vannucchi

http://www.w3.org/2001/XMLSchema#string

Chiara Rossi

http://www.w3.org/2001/XMLSchema#string

Elena Genovese

http://www.w3.org/2001/XMLSchema#string

Elisa Bianchi

http://www.w3.org/2001/XMLSchema#string

Elisa Rumi

http://www.w3.org/2001/XMLSchema#string

Enrico Tagliafico

http://www.w3.org/2001/XMLSchema#string

Laura Calabresi

http://www.w3.org/2001/XMLSchema#string

Mario Cazzola

http://www.w3.org/2001/XMLSchema#string

Roberta Zini

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes

A gain-of-function mutation of JAK2 in myeloproliferative disorders

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.

Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c

P2888

s41408-017-0010-2

P304

638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41408-017-0010-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paola Guglielmelli

Daniela Pietra

Rossella Manfredini

P577

2017-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29217833

http://www.w3.org/2001/XMLSchema#string

P932

5802509

http://www.w3.org/2001/XMLSchema#string